Plasma virus load measurements, CD4 counts, and clinical evaluations were performed on 63 HIV infected children in the Fall of 1994, and follow-up assessments were performed in the Fall,1996. At baseline, the median age was 5.54 years [Range 0.36 to 13.4 years], median log RNA copy number: 4.78(60,256 copies/ml) [1.7-6.34], median CD4 percent: 23% [0-50]. At the time of follow-up, the medians were: Age 7.58 years, CD4 18%, and log viral RNA copy number 4.32 (20,892). 8 Patients died during the period of follow-up, 13 others developed a new CDC Category C diagnosis, 42 had neither. A comparison of the median baseline values for those who died /had a new category C Dx/ neither showed: Age [5.10 / 4.25 / 6.08 years] CD4% [2 / 7 / 27.5%] Log RNA[5.63 / 5.07 / 4.46]. 17 of the 21 children with a new category C or death had an initial RNA PCR >4.6 logs (50,000 copies/ml). Three of the 4 with bad outcomes and <4.6 log RNA had baseline CD4 counts of <50 cells/cmm. Conclusion: Both CD4 count and RNA copy number define children at risk for HIV progression. Children with HIV RNA copy numbers <4.6 log(50,000 copies/ml) are unlikely to show progression within a 2 year period of follow-up, and the children with lower RNA numbers who are at risk of progression generally have low CD4 counts.Funded by NIAID AIDS Clinical Trials Group and Glaxo Wellcome, Co.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valentine, M., Jackson, C., Vavro, C. et al. Evaluation of Surrogate Markers and Clinical Outcomes in Two Year Follow-up of 63 HIV Infected Children † 778. Pediatr Res 41 (Suppl 4), 132 (1997). https://doi.org/10.1203/00006450-199704001-00798
Issue Date:
DOI: https://doi.org/10.1203/00006450-199704001-00798